Related coverage linked through entity extraction aliases.
Mar 12, 2026
The global next generation drug conjugates market is projected to grow from $3.9 billion in 2026 to $10.9 billion by 2033 at 15.3% CAGR, while the radionuclide drug conjugate segment is forecast to reach $20.22 billion by 2032 at 9.6% CAGR.
Feb 28, 2026
International Rare Disease Day on February 28 underscores challenges in diagnosing and treating rare genetic conditions, with patients facing years-long diagnostic delays and geographic barriers to accessing gene therapies.
Feb 16, 2026
Novartis has agreed to acquire Avidity Biosciences in the first half of 2026, obtaining its RNA therapeutics platform and neuromuscular disease pipeline. Avidity's cardiovascular RNA programs will be separated into a new independent company called Atrium.
